Saturday 8 June 2002 17.15 - 18.45 |
POSTER SESSION II
Receptors, Transcriptional control & Signalling
Cytogenetics / Molecular Biology
Acute Lymphoblastic Leukemia - Infectious
Acute Lymphoblastic Leukemia - Therapy
Acute Lymphoblastic Leukemia - Biology
Acute Myeloid Leukemia - Epidemiology
Acute Myeloid Leukemia - Biology
Chronic Lymphocytic Leukemia - Prognosis
Chronic Lymphocytic Leukemia - Biology
Chronic Lymphocytic Leukemia - Treatment
Lymphoproliferative Disorders / Immunotherapy - Biology
Lymphoproliferative Disorders / Immunotherapy - Treatment
Hodgkin's Lymphoma
Non Hodgkin's Lymphoma - Clinical
Non Hodgkin's Lymphoma - Pathology
Non Hodgkin's Lymphoma - Prognosis
Non Hodgkin's Lymphoma - Biology
Non Hodgkin's Lymphoma - Treatment
Miscellaneous
Chronic Myeloid Leukemia
IMATINIB for Chronic Myeloid Leukemia
Ph negative - Chronic Myeloproliferative disorders
Drug Resistance / Drug Pharmacology
Myelodysplastic Syndromes - Clinical
Myelodysplastic Syndromes - Biology
Myeloma - Biology
Myeloma - Prognostic factors, Diagnosis and staging
Myeloma - Thalidomide and novel drugs
Myeloma - Treatment
|